NOVEL ANTI-IL 13 ANTIBODIES AND USES THEREOF

Novel Anti-IL 13 Antibodies and Uses Thereof The present invention relates to anti-IL13 antibodies that bind specifically and with high affinity to both glycosylated and non-glycosylated human IL13, does not bind mouse IL13, and neutralize human IL13 activity at an approximate molar ratio of 1:2 (MA...

Full description

Saved in:
Bibliographic Details
Main Authors FUNG, SEK, CHUNG, MOYLE, MATTHEW, YAN, CHANGNING, HUANG, DAN, SINGH, SANJAYA, LU, MASON
Format Patent
LanguageEnglish
Published 30.04.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Novel Anti-IL 13 Antibodies and Uses Thereof The present invention relates to anti-IL13 antibodies that bind specifically and with high affinity to both glycosylated and non-glycosylated human IL13, does not bind mouse IL13, and neutralize human IL13 activity at an approximate molar ratio of 1:2 (MAb:IL13). The invention also relates to the use of these antibodies in the treatment of IL13-mediated diseases, such as allergic disease, including asthma, allergic asthma, non-allergic (intrinsic) asthma, allergic rhinitis, atopic dermatitis, allergic conjunctivitis, eczema, urticaria, food allergies, chronic obstructive pulmonary disease, ulcerative colitis, RSV infection, uveitis, scleroderma, and osteoporosis. (No suitable figure)
AbstractList Novel Anti-IL 13 Antibodies and Uses Thereof The present invention relates to anti-IL13 antibodies that bind specifically and with high affinity to both glycosylated and non-glycosylated human IL13, does not bind mouse IL13, and neutralize human IL13 activity at an approximate molar ratio of 1:2 (MAb:IL13). The invention also relates to the use of these antibodies in the treatment of IL13-mediated diseases, such as allergic disease, including asthma, allergic asthma, non-allergic (intrinsic) asthma, allergic rhinitis, atopic dermatitis, allergic conjunctivitis, eczema, urticaria, food allergies, chronic obstructive pulmonary disease, ulcerative colitis, RSV infection, uveitis, scleroderma, and osteoporosis. (No suitable figure)
Author MOYLE, MATTHEW
SINGH, SANJAYA
HUANG, DAN
FUNG, SEK, CHUNG
YAN, CHANGNING
LU, MASON
Author_xml – fullname: FUNG, SEK, CHUNG
– fullname: MOYLE, MATTHEW
– fullname: YAN, CHANGNING
– fullname: HUANG, DAN
– fullname: SINGH, SANJAYA
– fullname: LU, MASON
BookMark eNrjYmDJy89L5WTQ8fMPc_VRcPQL8dT19FEwNAYznfxdPF2DgUwXhdBgICPEwzXI1d-Nh4E1LTGnOJUXSnMzyLu5hjh76KYW5MenFhckJqfmpZbEB7sbmhoaWZo5GhoTVgEAvWUlqQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
ExternalDocumentID SG151296A1
GroupedDBID EVB
ID FETCH-epo_espacenet_SG151296A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:53:53 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_SG151296A13
Notes Application Number: SG20090019761
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090430&DB=EPODOC&CC=SG&NR=151296A1
ParticipantIDs epo_espacenet_SG151296A1
PublicationCentury 2000
PublicationDate 20090430
PublicationDateYYYYMMDD 2009-04-30
PublicationDate_xml – month: 04
  year: 2009
  text: 20090430
  day: 30
PublicationDecade 2000
PublicationYear 2009
RelatedCompanies TANOX, INC
RelatedCompanies_xml – name: TANOX, INC
Score 2.7320633
Snippet Novel Anti-IL 13 Antibodies and Uses Thereof The present invention relates to anti-IL13 antibodies that bind specifically and with high affinity to both...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Title NOVEL ANTI-IL 13 ANTIBODIES AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090430&DB=EPODOC&locale=&CC=SG&NR=151296A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdR3LasJAcBD7vLW2xb5zKDk1tGveh1DMy1g0EY3iTbLrSnuJ0qT09ztZTO3F2zALw-zCvHZeAE9WtcHayDJl-WoyRTMZ6kHdJArRTcY6lFDSqZqTh7ERTbX3uT5vwEfdCyPmhP6I4YgoUQzlvRT6erP7xPJFbWXxQj8RtX4LU8eX6-jYrkZYyb7rBKPETzzZ85xJT47HjjBsRhfjpAN0ok0Rss3cqidl89-ghGdwOEJaeXkODZ634MSr96614Hi4TXe34EjUZ7ICkVsZLC7gOU5mwUDqxmlf6Q8kogrQTSrHDkFfmqKKlNIoGAdJeAmPYZB6kYIMLP7uupj0ak7VK2jm65y3QaKMr4idqejaMc3WdCtTbYtWa6M5W5oZv4b2Pio3-49u4XSXGrmDZvn1ze_Rwpb0QTzOL0F8erU
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdR3JToNQcNLUpd4UNXUtB8NJopT9QEzZCsrStLTpjcArRi-0EYy_7_BSrJfeJvOSybyXzPZmA3jQmg3WSpbxq2eV8JJKUA_KqsALskrIMBdyYdg0J4eR4s2l16W87MBH2wtD54T-0OGIKFEE5b2m-nqz-8SyaW1l9ZR_Imr94iaGzbXRsd6MsOJs03AmsR1bnGUZszEXTQ1q2JQRxkkH6GBrNFBamE1Pyua_QXFP4XCCtMr6DDpFyUDPaveuMXAcbtPdDBzR-kxSIXIrg9U5PEbxwgnYUZT4vB-wgkhBM24cOwRtdo4qkk08Z-rE7gUMXCexPB4ZSP_ums7GLafiJXTLdVn0gc1J8S7omYiuHZF0SdYyUdfyZm10QVZqVlxBfx-V6_1HA-h5SRikgR-93cDJLk1yC93667u4Q2tb5_f0oX4BKj59pQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+ANTI-IL+13+ANTIBODIES+AND+USES+THEREOF&rft.inventor=FUNG%2C+SEK%2C+CHUNG&rft.inventor=MOYLE%2C+MATTHEW&rft.inventor=YAN%2C+CHANGNING&rft.inventor=HUANG%2C+DAN&rft.inventor=SINGH%2C+SANJAYA&rft.inventor=LU%2C+MASON&rft.date=2009-04-30&rft.externalDBID=A1&rft.externalDocID=SG151296A1